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Abstract
This is an editorial for the inauguration of the Medical Gas Research and addresses a particular issue of using
hyperbaric oxygen for stroke treatment.
Editorial
Stroke is one of the most expensive as well as the third
most common cause of disability and death in industria-
lized nations. In the US its prevalence is 5.8 million
causing about $73.7 billion dollars for the Year 2010.
Because of increasing life-span, these numbers are likely
to increase even more. Consequentially, prevention and
optimal management of those suffering will increase
health care expenditures. When I became a physician,
there was no effort to prevent stroke or to identify tran-
sient ischemic attacks (TIA). Consequently the Prince-
ton Conferences on stroke prevention and treatment
were founded. Having attended these conferences inter-
mittently since 1961, I suspect I am now a senior medi-
cal person. Few are aware that Irving S. Wright founded
this conference. He was a cardiologist who introduced
heparin to the United States from Sweden by initiating
the First Prospective Randomized Trial for therapy of
stroke in which I was a participant. It was he along with
Mrs. Mary Lasker, who developed the concept for the
Princeton Conferences in order to influence national
policy regarding research in heart disease and stroke.
Mrs. Lasker explained for me that one of her friends
experienced a stroke and was told there was no treat-
ment other than bed rest. Together they decided to
change this sorry state of affairs: Mrs. Lasker supplied
funds and Dr. Wright the impetus for inviting colleagues
from many disciplines to Princeton, New Jersey in the
bitter cold of January to develop a plan for national
action for stroke prevention and treatment. Thereafter,
Mrs. Lasker and her friend, Florence Mahoney, devoted
their efforts to this neglected field and urged President
Lyndon Johnson to change the name of the National
Institute for Neurological Diseases and Blindness to
include the word “stroke” so that a national effort could
be initiated in this in this neglected field.
The above is a preamble for my belief that innovations
in therapy for stroke have been neglected even though
many trials have been performed - and one is hyperbaric
oxygen therapy for acute stroke and rehabilitation.
Hyperbaric oxygen for stroke is not a new idea! Why
has it been so difficult to convince my colleagues in
healthcare that oxygen for those who are with acute
stroke deserves a randomized and prospective clinical
trial?
The administration of oxygen to people who suffer
cardiac events or hypoxic from respiratory disorders are
standard. We know that the brain requires more oxygen
than any other organ in the body; therefore, defies logic
to deny hyperbaric oxygen. Why is it that cardiac disor-
ders are routinely placed in oxygen and stroke victims
are not? Of all the organs in the body, the brain requires
t h em o s to x y g e na n di st h em o s tv u l n e r a b l et oh y p o x i a .
Consequently, it is not logical to limit its use to cardio-
pulmonary disorders and wound healing.
In here, I would like to show a letter from Edward
Teller from the Hoover Institution on War, Revolution
and Peace, from the Stanford University. Edward Teller
was one of the physicists who participated in the Man-
hattan Project and later on became known as the Father
of the Hydrogen Bomb (http://www.u-s-history.com).
December 5, 2000
James Toole, M.D.
Broman Gray School of Medicine
Medical Center Boulevard
Winston-Salem, North Carolina 27151
Dear Dr. Toole,
Dr. Neubauer visited me on his return from Australia.
He has informed me of your many accolades and the
substantial role you have played in the development of
the field of neurology. I want to take this opportunity to
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are looking into the potential use of hyperbaric oxygena-
tion for treatment of the acute stroke. I personally have
had experience with this modality for the past several
years. I had a stroke approximately five years ago and
the local hospital would not treat me. Dr. Neubauer
m a d ea r r a n g e m e n t sf o rm et oh a v eah o m ec h a m b e r
and since that time I have taken several treatments a
week. Although I may well have recovered and done
very well without the supplemental high dose oxygen,
my attendants stated very clearly that this has made
somewhat of a positive change in my ability to continue
an active work and lifestyle. There certainly should be a
place for the use of hyperbaric oxygenation in certain
disease states and especially in the field of neurology.
If is possible for you, send me quantitative statistically
significant statements about hyperbaric work in neurol-
ogy, particularly your own work. I should be greatly
interested.
Again, I congratulate you on your far-sightedness and
I trust that someday hyperbaric oxygenation may
become an accepted therapy.
Sincerely,
Edward Teller
ET: Imn
Cc: Dr. Neubauer
For inexplicable reasons, hyperbaric oxygen therapy
has been pushed aside and categorized as “unproved”
and no one sees fit to put it to the test with a properly
designed prospective randomized trial.
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